CJC-1295 (No DAC) + Ipamorelin 10mg
CJC-1295 (No DAC) + Ipamorelin 10 mg research peptide blend.
CJC-1295 (No DAC) and Ipamorelin are synthetic peptides commonly utilized in laboratory research involving growth hormone signaling pathways, receptor interactions, and neuroendocrine communication studies. Researchers investigate this peptide combination in models examining peptide-mediated biological processes and cellular signaling mechanisms.
This product is intended strictly for laboratory research purposes. It is not for human consumption, therapeutic use, veterinary use, or diagnostic use.
Specifications
| Compound | CJC-1295 (No DAC) + Ipamorelin 10mg |
|---|---|
| Category | Peptide |
| SKU | GRL-CJC1295-NODAC-IPA-10MG |
| Unit size | 10 mg |
| Price | $50.00 |
| Availability | In stock |
| Intended use | Laboratory research use only |
Compound identity
Reference facts for the compound itself, from PubChem (NIH). They describe the molecule, not a specific batch — batch purity is reported on the certificate of analysis. No public database record is confirmed for CJC-1295 (No DAC), so nothing is stated for it.
Ipamorelin
| CAS Registry Number | 170851-70-4 |
|---|---|
| Molecular formula | C38H49N9O5 |
| Molecular weight | 711.9 g/mol |
| PubChem CID | 9831659 |
CJC-1295 (No DAC) + Ipamorelin 10mg is also written CJC-1295 (No DAC) + Ipamorelin, CJC-1295 (No DAC) + Ipamorelin peptide, CJC1295(NoDAC)+Ipamorelin, CJC1295(NoDAC)+Ipamorelin peptide and CJC 1295 (No DAC) + Ipamorelin.
Research Applications
- Growth hormone signaling research
- Receptor interaction studies
- Neuroendocrine pathway investigations
- Peptide communication research
- Laboratory-based biological studies
Product Specifications
- Contents: CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg
- Quantity: 10 mg total per vial
- Appearance: Lyophilized powder
- Storage: Refrigerate upon receipt
- Research Use Only
Research questions about this compound
How do Ipamorelin and CJC-1295 (No DAC) differ in their mechanism?
Ipamorelin is a ghrelin mimetic that binds to the GHS-R, stimulating the pituitary gland to release GH . CJC-1295 (No DAC) is a GHRH analog that binds to the GHRH receptor, which serves as the natural trigger for GH secretion . They target two different receptors that both converge on the goal of increasing GH production.
Is the combination of these peptides supported by human clinical trials?
No. While CJC-1295 (DAC) has been studied in human clinical trials and Ipamorelin has been characterized in preclinical models , there is no robust body of human clinical trial data confirming the efficacy or safety of the combination of CJC-1295 (No DAC) and Ipamorelin.
What does "No DAC" mean in the context of CJC-1295?
DAC stands for Drug Affinity Complex. CJC-1295 with DAC is designed to bind to albumin in the bloodstream, significantly extending its half-life . The "No DAC" version lacks this modification, resulting in a shorter half-life and a different pharmacokinetic profile compared to the DAC-modified version studied in human trials .
Are these compounds approved for medical use?
The research compounds discussed here are primarily utilized in laboratory and experimental settings. They are not currently approved by major regulatory bodies for general human therapeutic use, and their clinical application remains a subject of ongoing research.
labels, lab notebooks, reorders
CJC-1295 (No DAC) + Ipamorelin 10mg — Reconstitution Calculator
For laboratory research use only. This tool computes the concentration of a reconstituted research solution and the volume that contains a target mass. Vial mass is a product specification, not a dose. It is not medical guidance and does not describe administration to humans or animals.
For laboratory research use only · not for human or animal use. Doses-per-bottle is pure arithmetic (vial mass ÷ target amount), not a dosing recommendation.
Compare CJC-1295 (No DAC) + Ipamorelin 10mg and Cerebrolysin 60 mg catalog facts →
